Drug Type Small molecule drug |
Synonyms S-021-0601 |
Target |
Mechanism M.tb bc1 inhibitors(mycobacterial cytochrome bc1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H13N3O2 |
InChIKeyGKRQRWSQVAEQCP-UHFFFAOYSA-N |
CAS Registry380559-40-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | IN | 15 Nov 2022 |